• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, July 14, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Korea University Guro Hospital Unveils Next-Gen Gamma Knife Esprit

Bioengineer by Bioengineer
July 9, 2026
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Korea University Guro Hospital has officially launched clinical operations of Esprit, the most advanced Gamma Knife system engineered for treating brain tumors and cerebrovascular diseases. This state-of-the-art platform signifies a breakthrough in radiosurgery, integrating the strengths of its predecessors, Perfexion and ICON, to deliver unparalleled precision and patient comfort.

Esprit ushers in a frame-free approach to Gamma Knife radiosurgery. Traditional procedures required invasive fixation, attaching a rigid frame to the patient’s skull via screws to ensure millimetric targeting accuracy. Esprit replaces this with a custom-fitted thermoplastic mask that immobilizes the patient comfortably without pain. This innovation is complemented by a highly sensitive real-time infrared motion management system capable of detecting movements with submillimeter accuracy of up to 0.15 mm. By continuously tracking even the slightest patient motion, Esprit eliminates the need for invasive frames, significantly reducing both physical discomfort and psychological distress during treatment.

The system’s enhanced precision is matched by its smart treatment planning software, Lightning, which employs artificial intelligence to revolutionize workflow. Where treatment plans previously demanded extensive manual optimization by clinicians, Lightning automates this process, accelerating planning time by over 80%. This automation also enables faster radiation delivery—with reductions of up to 50% in treatment duration. Faster, more efficient treatments not only decrease patient waiting times but also protect vital adjacent structures such as the optic and auditory nerves, known for their radiation sensitivity. Consequently, the Esprit system enables safer and more exact radiosurgical interventions.

With this technological leap, Korea University Guro Hospital strengthens its commitment to advancing patient-centered care. President Byung Wook Min emphasized that the installation of Esprit demonstrates the institution’s dedication to adopting innovations that improve outcomes for patients with complex brain disorders. The hospital aims to continue expanding access to cutting-edge medical infrastructure that elevates both the quality and experience of neurosurgical treatment.

Esprit represents more than incremental progress; it redefines the Gamma Knife radiosurgery paradigm by coupling non-invasive immobilization with AI-driven precision. This next-generation platform holds great promise for enhancing the safety, comfort, and efficacy of radiosurgery worldwide. As adoption spreads, patients afflicted by brain tumors and cerebrovascular conditions may soon benefit from treatments that are not only more accurate but markedly less stressful.

The integration of motion management technology with advanced AI planning software exemplifies the future of precision medicine, highlighting how engineering innovations can profoundly impact clinical outcomes. By automating complex workflows and improving treatment accuracy, Esprit reduces human error and variability, paving the way for consistently superior patient care.

Embodying a fusion of cutting-edge robotics, imaging, and artificial intelligence, the Esprit Gamma Knife system embodies a major step forward in the fight against debilitating brain diseases. Its full-scale clinical operation at Korea University Guro Hospital marks an exciting milestone, signaling a new era of radiosurgical excellence.

Subject of Research: Gamma Knife radiosurgery system advancements for brain tumors and cerebrovascular diseases
Article Title: Korea University Guro Hospital Launches Esprit, the Next-Generation Gamma Knife System
News Publication Date: Not specified
Web References: Not provided
References: Not provided
Image Credits: Not provided
Keywords: Gamma Knife treatment, Radiation therapy, Brain tumors, Radiosurgery, AI-powered treatment planning, Non-invasive fixation, Cerebrovascular diseases

Tags: advanced brain tumor treatmentAI-powered treatment planning softwarecerebrovascular disease therapyfaster radiation deliveryframeless radiosurgery systemGamma Knife EspritKorea University Guro Hospital medical innovationLightning automation in radiosurgeryminimally invasive Gamma Knife technologypatient comfort in stereotactic radiosurgeryreal-time infrared motion managementsubmillimeter targeting accuracy

Share12Tweet7Share2ShareShareShare1

Related Posts

Sustained virtual smoking cessation doubles quit rates for cancer patients

July 14, 2026

Researchers Identify Therapeutic Vulnerability in Aggressive Childhood Leukemia

July 14, 2026

Reactivated DRP1 Enables Resistance to MEK Inhibitors in Pancreatic Cancer Cells

July 14, 2026

Second Review Aims to Improve Targeting Accuracy

July 14, 2026

POPULAR NEWS

  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • Experimental Therapy Simultaneously Destroys Prostate Tumor Cells and Reactivates Antitumor Immunity

    46 shares
    Share 18 Tweet 12
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Age-Specific Molecular Subgroups in Pediatric and Young-Onset Meningiomas Require Tailored Risk Models

RASopathy Subtype Shapes Early Hypertrophic Cardiomyopathy Course, Study Finds

Informal Dementia Caregivers as Hidden Second Patients: Stress, Resilience, Burden

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.